822 related articles for article (PubMed ID: 18325442)
21. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease.
Baccouche H; Mahrholdt H; Meinhardt G; Merher R; Voehringer M; Hill S; Klingel K; Kandolf R; Sechtem U; Yilmaz A
Eur Heart J; 2009 Dec; 30(23):2869-79. PubMed ID: 19696191
[TBL] [Abstract][Full Text] [Related]
22. Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience.
Silva C; Moon JC; Elkington AG; John AS; Mohiaddin RH; Pennell DJ
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1076-9. PubMed ID: 18163027
[TBL] [Abstract][Full Text] [Related]
23. A clinical role for right ventricular endomyocardial biopsy.
Glazier JJ; Mortimer G; Daly KM
Ir Med J; 1989 Dec; 82(4):153-5. PubMed ID: 2621076
[TBL] [Abstract][Full Text] [Related]
24. Cardiac amyloidosis: hemodynamic, echocardiographic and endomyocardial biopsy studies.
Talwar KK; Kumar V; Agarwal R; Chopra P; Wasir HS
Indian Heart J; 1992; 44(6):387-90. PubMed ID: 1307087
[TBL] [Abstract][Full Text] [Related]
25. Endomyocardial biopsy: its diagnostic usefulness.
Thongtang V; Ratanarapee S; Chaithiraphan S; Panchavinnin P; Srivanasont N; Jootar P; Sahasakul Y; Charoenchob N
J Med Assoc Thai; 1992 Jan; 75(1):18-25. PubMed ID: 1602259
[TBL] [Abstract][Full Text] [Related]
26. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
Takase B; Nagata M
Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
[TBL] [Abstract][Full Text] [Related]
27. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
28. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].
Braun G; Sechtem U; Mahrholdt H
Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749
[TBL] [Abstract][Full Text] [Related]
29. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
Muellerleile K; Barmeyer A; Groth M; Lund GK
Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
[TBL] [Abstract][Full Text] [Related]
30. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.
Sparrow P; Amirabadi A; Sussman MS; Paul N; Merchant N
J Magn Reson Imaging; 2009 Nov; 30(5):942-6. PubMed ID: 19780184
[TBL] [Abstract][Full Text] [Related]
31. Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy.
Dickerson JA; Raman SV; Baker PM; Leier CV
Congest Heart Fail; 2013; 19(1):29-38. PubMed ID: 22963032
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
[TBL] [Abstract][Full Text] [Related]
33. Cardiac amyloidosis: five cases diagnosed by endomyocardial biopsy.
Silvestri F; Tanganelli P; Salvi A; Bussani R; Petrelli L; Pinamonti B; Camerini F
Appl Pathol; 1985; 3(1-2):69-77. PubMed ID: 3842071
[TBL] [Abstract][Full Text] [Related]
34. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
[TBL] [Abstract][Full Text] [Related]
35. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.
Murtagh B; Hammill SC; Gertz MA; Kyle RA; Tajik AJ; Grogan M
Am J Cardiol; 2005 Feb; 95(4):535-7. PubMed ID: 15695149
[TBL] [Abstract][Full Text] [Related]
36. [MR imaging in cardiac amyloidosis--morphology, function and late enhancement].
Hosch W; Libicher M; Ley S; Heye T; Schnabel P; Dengler TJ; Katus HA; Kauffmann GW; Kauczor HU; Kristen AV
Rofo; 2008 Jul; 180(7):639-45. PubMed ID: 18561066
[TBL] [Abstract][Full Text] [Related]
37. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions.
Hartke LP; Gilkeson RC; O'Riordan MA; Siwik ES
Congenit Heart Dis; 2006 Sep; 1(5):192-201. PubMed ID: 18377526
[TBL] [Abstract][Full Text] [Related]
39. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.
Hosch W; Bock M; Libicher M; Ley S; Hegenbart U; Dengler TJ; Katus HA; Kauczor HU; Kauffmann GW; Kristen AV
Invest Radiol; 2007 Sep; 42(9):636-42. PubMed ID: 17700279
[TBL] [Abstract][Full Text] [Related]
40. Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard.
Kristen AV; Dengler TJ; Katus HA
Am J Hematol; 2007 Apr; 82(4):328. PubMed ID: 16947323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
